J&J | Passifs Courants



Current Liabilities Changement Date
AbbVie USD 36.4B 2.35B 2025-03
Abbott USD 13.44B 435M 2025-06
Amgen USD 20.48B 2.53B 2025-06
AstraZeneca USD 33.54B 4.41B 2025-06
Baxter International USD 3.48B 3.03B 2025-03
Bayer EUR 29.78B 1.82B 2025-06
Becton, Dickinson and Co. USD 8.16B 469M 2025-06
Biogen USD 3.18B 2.11B 2025-06
Boston Scientific USD 5.06B 1.34B 2025-03
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
CONMED USD 294.84M 11.69M 2025-06
Cooper Companies USD 1.01B 12.9M 2025-04
Dexcom USD 3.31B 271.6M 2025-06
Edwards Lifesciences USD 1.39B 110.4M 2025-03
Eli Lilly USD 39.02B 8.95B 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
GlaxoSmithKline GBP 20.38B 453M 2025-06
Globus Medical USD 424.66M 39.96M 2025-06
Hologic USD 962.5M 27.2M 2025-06
Insulet USD 1.01B 489.7M 2025-06
Integra LifeSciences USD 929.81M 11.35M 2025-06
Intuitive Surgical USD 2.21B 197.4M 2025-06
J&J USD 56.9B 6.58B 2025-03
Medtronic USD 12.88B 1.04B 2025-04
Merck USD 26.04B 863M 2025-06
Merit Medical Systems USD 225.57M 28.75M 2025-06
Novartis USD 31.71B 95M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 29.06B 3.16B 2025-06
Stryker USD 7.29B 641M 2025-06
Tandem Diabetes Care USD 251.69M 36.48M 2025-06
Teva Pharmaceutical Industries USD 11.86B 704M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06
Zimmer Biomet Holdings USD 2.7B 404.6M 2025-06
Zoetis USD 3.37B 19M 2025-06


J&J Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.